Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?
- Authors
- Hall, F Scott; Drgonova, Jana; Jain, Siddharth; Uhl, George R
- Year
- 2013
- Journal
- Pharmacology & therapeutics
- PMID
- 23872493
- DOI
- 10.1016/j.pharmthera.2013.07.006
- PMCID
- PMC3797854
Substantial genetic contributions to addiction vulnerability are supported by data from twin studies, linkage studies, candidate gene association studies and, more recently, Genome Wide Association Studies (GWAS). Parallel to this work, animal studies have attempted to identify the genes that may contribute to responses to addictive drugs and addiction liability, initially focusing upon genes for the targets of the major drugs of abuse. These studies identified genes/proteins that affect responses to drugs of abuse; however, this does not necessarily mean that variation in these genes contributes to the genetic component of addiction liability. One of the major problems with initial linkage and candidate gene studies was an a priori focus on the genes thought to be involved in addiction based upon the known contributions of those proteins to drug actions, making the identification of novel genes unlikely. The GWAS approach is systematic and agnostic to such a priori assumptions. From the numerous GWAS now completed several conclusions may be drawn: (1) addiction is highly polygenic; each allelic variant contributing in a small, additive fashion to addiction vulnerability; (2) unexpected, compared to our a priori assumptions, classes of genes are most important in explaining addiction vulnerability; (3) although substantial genetic heterogeneity exists, there is substantial convergence of GWAS signals on particular genes. This review traces the history of this research; from initial transgenic mouse models based upon candidate gene and linkage studies, through the progression of GWAS for addiction and nicotine cessation, to the current human and transgenic mouse studies post-GWAS.
No figures extracted from this document.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| <i>BDNF</i> gene polymorphisms and substance use disorders: a systematic review. | Peregud D et al. | — | 2026 | → |
| Effects of positive mGlu5 modulation on D<sub>2</sub> signaling and nicotine-conditioned place preference: Mechanisms of epigenetic inheritance in a transgenerational model of drug abuse vulnerability in psychosis. | Peeters LD et al. | — | 2025 | → |
| Establishing Best Practices for Clinical GWAS: Tackling Imputation and Data Quality Challenges. | Casaburi G et al. | — | 2025 | → |
| G protein-coupled receptor (GPCR) pharmacogenomics. | Thompson MD et al. | — | 2024 | → |
| Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 Analogs. | Modestino EJ et al. | — | 2024 | → |
| Neuroepigenetic Editing. | Hamilton PJ et al. | — | 2024 | → |
| The association of genetic polymorphisms within the dopaminergic system with nicotine dependence: A narrative review. | Yang J et al. | — | 2024 | → |
| Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population. | Yuferov V et al. | — | 2022 | → |
| Common and distinguishing genetic factors for substance use behavior and disorder: an integrated analysis of genomic and transcriptomic studies from both human and animal studies. | Chang XW et al. | — | 2022 | → |
| FACTORS CONTRIBUTING TO THE ESCALATION OF ALCOHOL CONSUMPTION. | Bowen MT et al. | — | 2022 | → |
| Molecular genetics of cocaine use disorders in humans. | Fernàndez-Castillo N et al. | — | 2022 | → |
| Endocannabinoid Gene × Gene Interaction Association to Alcohol Use Disorder in Two Adolescent Cohorts. | Elkrief L et al. | — | 2021 | → |
| Genetic basis of variation in cocaine and methamphetamine consumption in outbred populations of <i>Drosophila melanogaster</i>. | Baker BM et al. | — | 2021 | → |
| Genetic Basis of Variation in Cocaine and Methamphetamine Consumption in Outbred Populations of<i>Drosophila melanogaster</i> | Baker BM et al. | — | 2021 | — |
| Identification of novel risk loci with shared effects on alcoholism, heroin, and methamphetamine dependence. | Sun Y et al. | — | 2021 | → |
| Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals. | Jordan CJ et al. | — | 2021 | → |
| Reduced cue-induced reinstatement of cocaine-seeking behavior in Plcb1 +/- mice. | Cabana-Domínguez J et al. | — | 2021 | → |
| Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach. | Emery MA et al. | — | 2020 | → |
| Implementation and Evaluation of a Text Message-Based Addiction Counseling Program (Text4Hope-Addiction Support): Protocol for a Questionnaire Study. | Agyapong VIO et al. | — | 2020 | → |
| Prospects for finding the mechanisms of sex differences in addiction with human and model organism genetic analysis. | Datta U et al. | — | 2020 | → |
| Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission. | Cadoni C et al. | — | 2020 | → |
| The Streetlight Effect: Reappraising the Study of Addiction in Light of the Findings of Genome-wide Association Studies. | Hall FS et al. | — | 2020 | → |
| Genetics of cocaine and methamphetamine consumption and preference in Drosophila melanogaster. | Highfill CA et al. | — | 2019 | → |
| Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine. | Ji Y et al. | — | 2018 | → |
| Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic. | Blum K et al. | — | 2018 | → |
| MiR-9, miR-153 and miR-124 are down-regulated by acute exposure to cocaine in a dopaminergic cell model and may contribute to cocaine dependence. | Cabana-Domínguez J et al. | — | 2018 | → |
| Neuroepigenetic Editing. | Hamilton PJ et al. | — | 2018 | → |
| Neuroepigenetics and addiction. | Walker DM et al. | — | 2018 | → |
| The Role of Cell Adhesion Molecule Genes Regulating Neuroplasticity in Addiction. | Muskiewicz DE et al. | — | 2018 | → |
| Analysis of shared homozygosity regions in Saudi siblings with attention deficit hyperactivity disorder. | Shinwari JMA et al. | — | 2017 | → |
| A Spontaneous Mutation in <i>Taar1</i> Impacts Methamphetamine-Related Traits Exclusively in DBA/2 Mice from a Single Vendor. | Reed C et al. | — | 2017 | → |
| Association of the PLCB1 gene with drug dependence. | Cabana-Domínguez J et al. | — | 2017 | → |
| Research Domain Criteria versus DSM V: How does this debate affect attempts to model corticostriatal dysfunction in animals? | Young JW et al. | — | 2017 | → |
| Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. | Schwantes-An TH et al. | — | 2016 | → |
| Fischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug Addiction. | Cadoni C | — | 2016 | → |
| Mitochondrial DNA Haplogroup A Decreases the Risk of Drug Addiction but Conversely Increases the Risk of HIV-1 Infection in Chinese Addicts. | Zhang AM et al. | — | 2016 | → |
| Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies. | Volkow ND et al. | — | 2016 | → |
| Sex-Specific Alterations of White Matter Developmental Trajectories in Infants With Prenatal Exposure to Methamphetamine and Tobacco. | Chang L et al. | — | 2016 | → |
| Systems genetics of intravenous cocaine self-administration in the BXD recombinant inbred mouse panel. | Dickson PE et al. | — | 2016 | → |
| NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity. | Schoenthaler SJ et al. | — | 2015 | → |
| Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence. | Fernàndez-Castillo N et al. | — | 2015 | → |
| Personality traits and vulnerability or resilience to substance use disorders. | Belcher AM et al. | — | 2014 | → |
| Pharmacogenetics of the G protein-coupled receptors. | Thompson MD et al. | — | 2014 | → |
| Reducing substance use during adolescence: a translational framework for prevention. | Stanis JJ et al. | — | 2014 | → |
| The role of the habenula in drug addiction. | Velasquez KM et al. | — | 2014 | → |
| What do Differences in Emotional Regulation in Individuals Addicted to Different Substances Tell us About Addiction Treatment? | Scott Hall F | — | 2013 | → |